NGM Biopharmaceuticals, Inc. Pre-Tax Profit Margin 2018-2023 | NGM
NGM Biopharmaceuticals, Inc. pre-tax profit margin from 2018 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $0.00B | $-0.14B | -3575.00% |
| 2023-09-30 | $0.02B | $-0.15B | -686.36% |
| 2023-06-30 | $0.03B | $-0.17B | -582.76% |
| 2023-03-31 | $0.04B | $-0.18B | -494.44% |
| 2022-12-31 | $0.06B | $-0.16B | -294.55% |
| 2022-09-30 | $0.06B | $-0.15B | -263.79% |
| 2022-06-30 | $0.07B | $-0.14B | -195.65% |
| 2022-03-31 | $0.08B | $-0.13B | -160.26% |
| 2021-12-31 | $0.08B | $-0.12B | -153.16% |
| 2021-09-30 | $0.08B | $-0.12B | -156.41% |
| 2021-06-30 | $0.08B | $-0.12B | -150.00% |
| 2021-03-31 | $0.09B | $-0.11B | -131.76% |
| 2020-12-31 | $0.09B | $-0.10B | -118.39% |
| 2020-09-30 | $0.10B | $-0.09B | -92.86% |
| 2020-06-30 | $0.10B | $-0.07B | -74.23% |
| 2020-03-31 | $0.10B | $-0.05B | -52.94% |
| 2019-12-31 | $0.10B | $-0.04B | -41.35% |
| 2019-09-30 | $0.12B | $-0.01B | -10.83% |
| 2019-06-30 | $0.12B | $-0.01B | -8.40% |
| 2019-03-31 | $0.12B | $-0.01B | -4.31% |
| 2018-12-31 | $0.11B | $-0.00B | -0.92% |
